Preclinical Research Guidelines

Acute Toxicity Study

Overview

What is an Acute Toxicity Study?

An acute toxicity study is a short-term toxicity test conducted to evaluate the adverse effects produced by a test substance following a single dose or multiple doses administered within 24 hours (or a single inhalation exposure).

Animals are observed for signs of toxicity and mortality for at least 14 days. The study is used to identify hazards, classify chemicals, and provide information for risk assessment.

Observation Period: Acute toxicity testing involves administering a test substance at defined dose levels to experimental animals and monitoring them for signs of toxicity over a specified observation period, typically ranging from 24 hours to 14 days.

Regulatory Standards

OECD Test Guidelines

OECD test guidelines governing subacute toxicity studies across oral, dermal, and inhalation routes of administration.

OECD 420
- Acute Oral Toxicity (Fixed Dose Procedure)
OECD 423
- Acute Oral Toxicity (Acute Toxic Class Method)
OECD 425
- Acute Oral Toxicity (Up-and-Down Procedure)
OECD 403
- Acute Inhalation Toxicity (Standard Protocol)
OECD 436
- Acute Inhalation Toxicity (Acute Toxic Class Method)
OECD 433
- Acute Inhalation Toxicity (Fixed Concentration Procedure)
OECD 402
- Acute Dermal Toxicity (Fixed Dose Procedure)

Scientific Basis

Principles

Acute toxicity testing is based on administering a test substance as defined dose levels to experimental animals and monitoring them for a sign of toxicity over a specific observation period typically 14 days.
The severity, onset, duration of reversibility of toxic effects are recorded. Animals are observed for changes in behavior,physiological,functions,mortality . At the end of the study, gross pathological examinations are performed to identify any treatment-related abnormalities.

Study Goals

Objectives of Sub Chronic toxicity study

Each acute toxicity study is designed to achieve specific scientific and regulatory objectives.

Determination of the toxic effects of a test substance following single exposure
Identification of clinical signs associated with toxicity
Determination of Mortality and morbidity rates
Identification of target organs affected by the test substances
Establishment of dose levels for subsequent subacute and chronic toxicity studies
Estimation of lethal dose (LD50) or toxic dose range
Assessment of potential hazards to humans and animals

Research Models

Experimental Animals

Standardized rodent models are selected based on regulatory acceptability and biological relevance.

Wistar Rat (Rat Model)
Sprague Dawley Rat (Rat Model)
Swiss Albino Mice (Mouse Model)
BALB/C Mice (Mouse Model)

Facility Standards

Environmental Conditions

Controlled housing conditions are maintained throughout the study to minimize variability and ensure animal welfare compliance.

Temperature22 ± 3°C

Relative Humidity30–70% (preferred 50–60%)

Lighting Cycle12h Light / 12h Dark

Animal RoomClean, well-ventilated, controlled environment

DietStandard rodent diet, ad libitum

WaterPotable drinking water, ad libitum

Cage OccupancyDensity for unobstructed clinical observation

Exposure Methods

Routes of Administration

The route of administration is selected based on the intended use of the test substance and the applicable OECD guideline.

Oral Route: Oral Gavage, Stomach tube, Intubation cannula
Dermal Route: Topical Application, Dermal Application
Inhalation Route: Inhalation Chamber, Head/nose-only exposure, Whole-body Exposure

Industry Use Cases

Suitable Product Types

Sub-Acute toxicity studies are essential for determining the safety profile of a wide range of products before clinical use or regulatory approval.

Pharmaceutical Products
Chemical Products
Nutraceutical Products
Herbal Products
Medical Devices

CONNECT WITH OUR SCIENTISTS